According to Repare Therapeutics's latest financial reports and stock price the company's current Operating Margin is -139.46%. At the end of 2023 the company had an Operating Margin of -201.79%.
Year | Operating Margin | Change |
---|---|---|
2023 | -201.79% | 1813.77% |
2022 | -10.54% | -99.26% |
2021 | -1,428.76% | -96.48% |
2020 | -40,549.63% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.